Panama opens process to obtain manufacturing license for medical cannabis derivatives

Opening of the call process for companies interested in obtaining a license to manufacture medical cannabis derivatives

The Ministry of Health (MINSA), through the National Directorate of Pharmacy and Drugs, invites applicants to participate in the selection process of companies interested in obtaining the License to Manufacture Medicinal Cannabis Derivatives.

Companies interested in participating can download the rules of the call on the MINSA website, which include the requirements that applicants must meet to be considered in the selection process.

According to the schedule for submitting proposals and their qualification, a meeting will be held on June 19 to standardize the bases for the selection and until August 29, consultations will be received and clarifications will be made. The last day to receive applications is September 18, 2023 at 4:00 pm.

It is important to remember that according to Law 242 of October 13, 2021, only seven companies that meet all the requirements will be able to carry out the entire production chain from planting, controlled environment, harvest, drying, to dispensing.

The process is governed by Law 242 of October 13, 2021, and Executive Decree No. 121 of September 1, 2022, as well as Law 1 of 2022, Law 14 of 2016 and its due regulations and other regulations applicable to the selection process.

For assistance related to this call process, contact us at consultas@stagingcd.com.